CNTA logo

Centessa Pharmaceuticals plc (CNTA) Cash from investing

annual CFI:

$31.28M+$158.78M(+124.53%)
December 31, 2024

Summary

  • As of today (September 15, 2025), CNTA annual cash flow from investing activities is $31.28 million, with the most recent change of +$158.78 million (+124.53%) on December 31, 2024.
  • During the last 3 years, CNTA annual CFI has fallen by -$31.97 million (-50.54%).
  • CNTA annual CFI is now -50.54% below its all-time high of $63.25 million, reached on December 31, 2021.

Performance

CNTA Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

quarterly CFI:

-$41.36M+$181.89M(+81.48%)
June 1, 2025

Summary

  • As of today (September 15, 2025), CNTA quarterly cash flow from investing activities is -$41.36 million, with the most recent change of +$181.89 million (+81.48%) on June 1, 2025.
  • Over the past year, CNTA quarterly CFI has increased by +$14.11 million (+25.43%).
  • CNTA quarterly CFI is now -164.88% below its all-time high of $63.74 million, reached on March 31, 2021.

Performance

CNTA quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

TTM CFI:

-$194.61M+$14.11M(+6.76%)
June 1, 2025

Summary

  • As of today (September 15, 2025), CNTA TTM cash flow from investing activities is -$194.61 million, with the most recent change of +$14.11 million (+6.76%) on June 1, 2025.
  • Over the past year, CNTA TTM CFI has dropped by -$186.83 million (-2403.28%).
  • CNTA TTM CFI is now -405.33% below its all-time high of $63.74 million, reached on March 31, 2021.

Performance

CNTA TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CNTA Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+124.5%+25.4%-2403.3%
3 y3 years-50.5%-10000.0%-10000.0%
5 y5 years+100.0%--

CNTA Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-50.5%+124.5%-184.0%+81.5%-722.1%+6.8%
5 y5-year-50.5%+124.5%-164.9%+81.5%-405.3%+6.8%
alltimeall time-50.5%+124.5%-164.9%+81.5%-405.3%+6.8%

CNTA Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$41.36M(-81.5%)
-$194.61M(-6.8%)
Mar 2025
-
-$223.24M(-993.5%)
-$208.71M(-767.2%)
Dec 2024
$31.28M(-124.5%)
$24.98M(-44.5%)
$31.28M(-360.8%)
Sep 2024
-
$45.00M(-181.1%)
-$11.99M(+54.3%)
Jun 2024
-
-$55.46M(-431.1%)
-$7.77M(-67.1%)
Mar 2024
-
$16.75M(-191.6%)
-$23.62M(-81.5%)
Dec 2023
-$127.50M(>+9900.0%)
-$18.29M(-137.2%)
-$127.50M(+16.3%)
Sep 2023
-
$49.22M(-169.0%)
-$109.66M(-31.0%)
Jun 2023
-
-$71.31M(-18.1%)
-$158.90M(+81.0%)
Mar 2023
-
-$87.12M(>+9900.0%)
-$87.81M(+9338.0%)
DateAnnualQuarterlyTTM
Dec 2022
-$930.40K(-101.5%)
-$450.40K(+3140.3%)
-$930.40K(+33.4%)
Sep 2022
-
-$13.90K(-93.9%)
-$697.40K(+10.4%)
Jun 2022
-
-$227.50K(-4.7%)
-$631.90K(-13.1%)
Mar 2022
-
-$238.60K(+9.8%)
-$727.10K(-101.1%)
Dec 2021
$63.25M(>+9900.0%)
-$217.40K(-521.3%)
$63.25M(-0.3%)
Sep 2021
-
$51.60K(-116.0%)
$63.47M(+0.1%)
Jun 2021
-
-$322.70K(-100.5%)
$63.41M(-0.5%)
Mar 2021
-
$63.74M
$63.74M
Dec 2020
$0.00(0.0%)
-
-
Dec 2019
$0.00
-
-

FAQ

  • What is Centessa Pharmaceuticals plc annual cash flow from investing activities?
  • What is the all time high annual CFI for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc annual CFI year-on-year change?
  • What is Centessa Pharmaceuticals plc quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc quarterly CFI year-on-year change?
  • What is Centessa Pharmaceuticals plc TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Centessa Pharmaceuticals plc?
  • What is Centessa Pharmaceuticals plc TTM CFI year-on-year change?

What is Centessa Pharmaceuticals plc annual cash flow from investing activities?

The current annual CFI of CNTA is $31.28M

What is the all time high annual CFI for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high annual cash flow from investing activities is $63.25M

What is Centessa Pharmaceuticals plc annual CFI year-on-year change?

Over the past year, CNTA annual cash flow from investing activities has changed by +$158.78M (+124.53%)

What is Centessa Pharmaceuticals plc quarterly cash flow from investing activities?

The current quarterly CFI of CNTA is -$41.36M

What is the all time high quarterly CFI for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high quarterly cash flow from investing activities is $63.74M

What is Centessa Pharmaceuticals plc quarterly CFI year-on-year change?

Over the past year, CNTA quarterly cash flow from investing activities has changed by +$14.11M (+25.43%)

What is Centessa Pharmaceuticals plc TTM cash flow from investing activities?

The current TTM CFI of CNTA is -$194.61M

What is the all time high TTM CFI for Centessa Pharmaceuticals plc?

Centessa Pharmaceuticals plc all-time high TTM cash flow from investing activities is $63.74M

What is Centessa Pharmaceuticals plc TTM CFI year-on-year change?

Over the past year, CNTA TTM cash flow from investing activities has changed by -$186.83M (-2403.28%)
On this page